Nabriva Therapeutics LEAP 1 Phase 3 Trial Topline Results Conference Call Monday September 18, 2017 8:30 AM EDT Click here for webcast Live Teleconference Information Primary # - 866-411-8292 Secondary # - 704-908-0383 Passcode - 86032729
